Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Sangamo cell therapy increases CD4+ T-cell counts in patients with HIV

March 20, 2012

Prostaglandin E2 derivative shows therapeutic potential in preclinical and clinical studies

March 19, 2012

ROCK inhibitor and calcium channel blocker show synergy in phase I trial

March 19, 2012

New strategy shows promise to eradicate latent HIV-1

March 19, 2012

New P2X4 receptor antagonist is active in models of neuropathic pain

March 16, 2012

Studies demonstrate various therapeutic applications for SEH inhibition

March 16, 2012

Anti-fibrillogenic agents designed via out-of-plane substitutions show therapeutic potential

March 16, 2012

Telaprevir improves hepatitis C therapy in HIV-1-coinfected patients

March 16, 2012

HIV peptide-loaded dendritic cells evaluated in DALIA trial

March 15, 2012

NME protects human bone marrow progenitor cells against radiation

March 15, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...